News & Updates
Filter by Specialty:
Shorter flare duration best indicator of treatment success in gout
Patients with gout consider flare duration, flare frequency, and pain severity when thinking about treatment efficacy over time, according to a study. Of these factors, shorter flare duration is deemed to be the most common indicator of successful treatment.
Shorter flare duration best indicator of treatment success in gout
14 Dec 2021App-delivered mindfulness training eases anxiety
Mindfulness training (MT) delivered through an app (Unwinding Anxiety) significantly alleviates anxiety, a study has shown. Increases in psychological nonreactivity and reductions in worry mediate the effects of this app, which suggests a specific targeting of reinforcement learning.
App-delivered mindfulness training eases anxiety
14 Dec 2021Antidepressant therapy: To continue or not?
In individuals who had been on antidepressant therapy for at least 9 months but felt well enough to consider discontinuing, the risk of relapse of depression was greater among those who stopped vs those who carried on with their current regimen, the ANTLER* trial has shown.
Antidepressant therapy: To continue or not?
14 Dec 2021Losing weight lowers risk of hypertensive disorders of pregnancy
Lifestyle interventions or bariatric surgery leading to preconceptional weight loss effectively reduces the risk of hypertensive disorders of pregnancy (HDP), such as pregnancy-induced hypertension (PIH) and pre-eclampsia (PE), reports a recent meta-analysis.
Losing weight lowers risk of hypertensive disorders of pregnancy
14 Dec 2021Radiographic progression of interstitial lung disease portends long-term mortality risk
Among patients with systemic sclerosis-interstitial lung disease (SSc-ILD), radiographic progression of ILD over time is predictive of elevated long-term mortality, as shown in a study.